Resumption of methimazole after 131I therapy of hyperthyroid diseases: effect on thyroid function and volume evaluated by a randomized clinical trial | Zendy

Steen Joop Bonnema | Zendy; FN Bennedbæk | Zendy; Jeppe Gram | Zendy; Annegrete Veje | Zendy; J. Marving | Zendy; László Hegedűs | Zendy

Open Access

Resumption of methimazole after 131I therapy of hyperthyroid diseases: effect on thyroid function and volume evaluated by a randomized clinical trial

Author(s) -

Steen Joop Bonnema,

FN Bennedbæk,

Jeppe Gram,

Annegrete Veje,

J. Marving,

László Hegedűs

Publication year - 2003

Publication title -

european journal of endocrinology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.897

H-Index - 148

eISSN - 1479-683X

pISSN - 0804-4643

DOI - 10.1530/eje.0.1490485

Subject(s) - euthyroid , medicine , thyroid , thyroid function , confidence interval , methimazole , iodine , graves' disease , randomized controlled trial , endocrinology , antithyroid agent , radioiodine therapy , gastroenterology , thyroid cancer , materials science , metallurgy

Retrospective studies have indicated that anti-thyroid drugs (ATD) might possess a radioprotective effect, leading to a higher rate of recurrence of hyperthyroidism after iodine-131 ((131)I) therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research